Furthermore, human tumor xenograft studies in mice have repeatedly demonstrated that inhibiting Stat3 results in decreased tumor growth and improved animal survival [4] by inducing apoptosis in tumor cells, inhibiting angiogenesis [9] and enhancing anti-tumor immune-mediated cytotoxicity [2], [10]. The gene discussed is STAT3; the disease is neoplasm.